Scotiabank analyst George Farmer maintains $Syndax Pharmaceuticals (SNDX.US)$ with a hold rating, and maintains the target price at $18.
According to TipRanks data, the analyst has a success rate of 48.8% and a total average return of 9.9% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Syndax Pharmaceuticals (SNDX.US)$'s main analysts recently are as follows:
The FDA's approval of Revuforj has dissipated prior concerns surrounding the three-month extension. The implementation of a boxed warning for differentiation syndrome on Revuforj is anticipated to be consistent across the broader menin-inhibitor class, thus not posing a competitive disadvantage.
The approval of REVUFORJ, revumenib, for relapsed or refractory acute leukemia with KMT2A translocation in adults and pediatric patients was granted by the FDA six weeks prior to the anticipated PDUFA date. The safety and efficacy indications are largely in line with expectations. Additionally, the recommendation for initial QTc monitoring with treatment is viewed as not being burdensome.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
